Has Craig Parman received payments from drug or device companies?

Yes. Drug and device makers reported $2,973 in general payments to Craig Parman across 214 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Craig Parman did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Craig Parman come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Craig Parman

Family Medicine · Haysville, KSNPI 1669481206

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 214 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Pfizer at 28.5% of the total. Reporting peaked in 2021 at $949 and has fallen 77.3% since, to $216 in 2022.

$2,973in general payments, 2019–2025

Across 214 payments — averaging $13.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$846
Amgen$230
Lilly USA, LLC$229
Novo Nordisk$211
Sanofi-aventis U.S. LLC$197
AbbVie$195
plus $1K from 20 others

What the payments were for

Food & beverage$2,973100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	73	$846
Amgen	14	$230
Lilly USA, LLC	16	$229
Novo Nordisk	15	$211
Sanofi-aventis U.S. LLC	13	$197
AbbVie(2 entities)	14	$195
AstraZeneca	10	$177
Amarin Pharma, Inc.	8	$143
Merck	8	$103
Johnson & Johnson	7	$101
Boehringer Ingelheim	4	$67
Takeda Pharmaceuticals U.S.A., Inc.	4	$60
Collegium Pharmaceutical, Inc.	4	$55
GSK	4	$48
Abbott	3	$46
Novartis	3	$45
Sanofi Pasteur Inc.	2	$42
Sunovion Pharmaceuticals Inc.	2	$33
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$29
Astellas Pharma US Inc	2	$27
Biohaven Pharmaceuticals, Inc.	1	$19
Upsher-smith Laboratories LLC	1	$17
Dermira, Inc.	1	$16
Jazz Pharmaceuticals Inc.	1	$13
Eisai Inc.	1	$13
Daiichi Sankyo Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

COLOGUARD$107

How this compares

$2,973 in reported general payments places this provider in the 80th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas →

Other family medicine in Haysville

Heba FergusonHaysville$10K
Bradley HarrisonManhattan$314K
Mila MeansWichita$241K
Scott AveryJunction City$195K
Kent KiracofeManhattan$189K
Terry McGeeneyLeawood$147K
Cole GillenwaterWichita$62K
David StricklandLawrence$53K
Kyle PlatzManhattan$51K
Eric AspinwallKansas City$28K

See the full list for Kansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →